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In conclusion, TEC atheractomy led to enhanced clinical safety in percu-
taneous revascularization during acute ischemicstates, while augmenting-6-
month outcome. Ita routine use during acute ischemic syndrome revaecular-
izatlon may now be considered for the technloally suitable vessel. Six month
follow up to be presented.
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FrequentAfterPrimeryPTCAforAcute
MyocardlalInfarction
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P.G.Steg, P.Assayag. Service de Cardiologie, Hopital Bichat, Paris, France
No-reflow, defined as incomplete recovery of myocardial perfusion after re-
establishment of patency of the infarct-related artery during acute myooardial
infarction (Ml), has been linked to worse prognosis, including heart failure
and left ventricular remodeling.
We prospectively studied no reflow by myocardial contrast echocerdio-
grephy (MCE) in 14 Pts with acute Ml (10 anterior and 4 inferior), treated by
primary PTCAwithin 6 hours (average time to TIMI 3 patency: 212 * 12 rein)
of Ml onset. MCE was performed by injection of sonicated ioxaglate in both
Infarc+ and non-infarct-related aiteries during corona~ angiography acutely.
Coronary angiography and simultaneous MCE were repeated 9 + 1 days
later. Myocerdial perfusion was graded semi-quantitatively by 2 independent
observers using a score of O, 0.5 and 1 for each ASE echocardiographic
segment from the myocardial area at risk (defined as hype- or akinetic seg-
ments; n = 95 segments). Echographic wall motion was graded on a score
from 1 (normokinesia) to 3 (akinesia).
After PTCA-induced TIMI 3 patency, MCE score was Oin 20%, 0.5 in 27%
and 1 In 53% of segments, respectively. At restudy, this score was Oin 10%,
0.5 in 14% and 1 in 76% of segments, respectively. Therefore, perfusion
was abnormal in 47% of segments acutely and in only 24% at predischarge
(p = 0.006). The average perfusion score per segment was O.W + 0.04
acutely and increased to 0.82 + 0.03 at restudy (p= 0.001). This increase in
“perfusion score was associated with a decrease in the average wall motion
grade: 2.8 * 0.04 acutely and 2.5+ 0.08 at day 9 (p < 0.01).
This important recovev of MCE-assessad myocardial perfusion within
daya (despite substantial acute no-reflow) suggests that primaty PTCA-
induced reperfusion results in effective protection of the myccardial mi-
crovasculature and may explain the early functional recovery,assessed by
echocardiography.
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consecutive patients with AMI for direct
PTCA between 1991 and 1995. Twenty (Group 1) received intracoronary
adenoeine (4 mg over 4 minutea) and 20 intracoronaty saline (Group ii).
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+ O I 2.7 + 0.6 in group 11,p = 0.043), in
the incidence of Q wave Ml (50% in group i vs 80% in group H,p = 0.0467)
end of clinically assesed LV failure (O% in groupI vs 20% in group H,p =
0.035). Peak CPK value was higher in saline patients (1994 + 1782 UI in
group I va 2803 + 1857 UI in group H,p = NS).
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Salutary effect of nlcorandll, a K+-ATP channel opener, on restoration of
myocardial blood flow and functional improvement after ooronary revascular-
ization was investigated. Twenty patients with first anterior acute myocardial
infarction (AMI) who underwent coronary recanalization within 6 hours of the
onset were divided Into 2 groups: 10’patients who raoeived an adjunotive
intracomnary dose of 2 mg of nicorandil just after successful coronary reflow
(group A) and the other 10 patients who obtained successful coronary reflow
only (group B). Myocardial contrast echocardiography (MCE) was performed
beforeand15 minutes affercoronary reflow and 5minutesafterthe nicorandil
administration. MCE imageswere analyzed to determine peak contrast inten-
sity in the infarct and non-infarct areas, and their ratio (Pl ratio) was used to
assess microvascular integrity in the infarcl area. Regional wall motion in the
infarct area was serially assessed by two-dimensional echocardiography just
after coronary reflow and a month later (scores of O,normal, to 4, dyskinetic).
Thare was no difference in the wall motion score or the PI ratio juat after
coronary reflow between groups A (30 segments) and B (31 segments). ln-
tracoronary administration of nicorandil in group A improved the PI ratio from
0.27 + 0.25to 0.53 + 0.42 (p < 0.001), and provided greater improvement in
the wall motion score in a month compared to group B (2.8+ 0.7to 1.7 + 0.9
vs 2.7 & 0.5 to 2.4 + 0.8; p < 0.01). Thus we concluded that Intraooronaty
nicorandil administration restored blood flow within the infarct myocardium
and provided greater functional improvement in a month, suggestingthe
usefulnessof nicorandiladministrationas an adjunctivetreatmentfollowing
coronaryreflowinAMI patients,
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Leftventriculardilatationandprogreaaivesystolicdysfunctionfollowingacute
myocerdialinfarction(AMI) havebeen preventedby ACE inhibition.The rel-
ative importanceof aldosteronein this reaponse is uncertain. In a placebo
controlled, double blinded, randomized trial, we compared remipril (R) and
spironolactone (S), an aldostarone receptor antegoniet, in patients with im-
paired ejection fraction (EF) post AMI. Geometric left ventricular remodeling
was assessed baseline (B) and foliowing 6 months (m) of treatment. Patients
were randomly assigned to placebo (P, n = 18), R (2.5 mg b.i.d., n = 22)
or S (25 mg t.i.d., n = 15) on day 5 poet Ml. Groups were simiiar in age,
gender, AMI location, Killip class, incidence of thromboiysis (mean = 41%),
angioplasty (mean = 8%), surgical revascularization (mean = 5%) or addi-
tional medication: aspirin (mean = 90%), nitrates (mean = 31%), B-blockers
(mean = 28%), diuretics (mean = 18%) and digitalis (mean = 9%). Ejec-
tion fraction (EF), left ventricular end diastolic (EDVJand end systolic (ESV)
volumes were obtained by mitigated radionuclide angiography. Values are
expressed as mean + standard error.
EF(“A) EOV(ml) ESV(ml)
B 6m B 6m B 6m
P 39* 3 33* 3 127& S 166i 12 75& 6 109l 11
R 3sAZ 40* 2* 126& 7 143l 9 79& 6
s
88k 7*
33• 3 36& 3* 126+ 11 143* 10 S2+ 8 67& 6“
*p< 0,05,ANOVAofthedilferencas(treatedgroupsvs.placebo,)
We conclude that R and S provided comparable prevention of ventricular
dilatation and further decline in systolic dysfunction suggesting aldosterone
contributes to this geometrical remodeling and that antagonism of its receptor
may be equally efficacious to ACE inhibition.
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Previous experimental studies have reported that the inhibition of throm-
